BoostMe

Earlier prime-BOOST schedule to improve MEasles protection in high burden settings

Funder

Bill and Melinda Gates Foundation

Type of Study

Clinical trial

Sponsor

University of Oxford

Country

Uganda

Chief Investigator

Dr Ezekiel Mupere

Participants

Infants

Summary

The study aims to compare the safety and immunogenicity of early (6 months) vs standard (9 months) dosing with measles-containing vaccine, in Ugandan children.

This study is currently in set-up phase. More details are to be shared later.

Duration

TBD